INTRODUCTION
Cyclic AMP (cAMP) plays an important role in different signaltransduction pathways in Dictyostelium discoideum. On starvation, a group of cells starts to secrete cAMP which is recognized by surrounding cells. The cells move towards the centre of the cAMP secretion. Eventually, all the cells that join the aggregate develop into a multicellular structure, the fruiting body. This fruiting body consists of viable spore cells on top of a stalk of dead cells [see Loomis (1985) ].
Dictyostelium cells have several receptors that interact with cAMP: cell surface receptors (cARs) to detect extracellular cAMP as a first messenger, intracellular cAMP-dependent protein kinase (PKA) to detect intracellular cAMP as a second messenger, and extracellular and intracellular cyclic nucleotide phosphodiesterase to degrade cAMP (see Van Haastert et al., 1991) . The genes encoding these proteins have been identified (Lacombe et al., 1986; Mutzel et al., 1987; Klein et al., 1988; Saxe et al., 1991) . The derived amino acid sequences of cARs predict proteins with seven putative spanning segments and a cytosolic C-terminal domain, indicative of G-protein-coupled receptors (Klein et al., 1988) . The deduced structure of the regulatory subunit of PKA is very different from that of cARs; it shows strong homology with mammalian regulatory subunits of PKA (Mutzel et al., 1987) . Using analogues of cAMP it has been shown that these receptors possess very different cyclic nucleotide-binding specificities (De Wit et al., 1982; Van Haastert and Kien, 1983; Van Ments-Cohen and Van Haastert, 1989) . Cyclic nucleotide derivatives that bind specifically to cARs or to intracellular PKA have been used to demonstrate the role of each of the receptors (Van Haastert and Kien, 1983; Van Haastert, 1983; Schaap and Van Driel, 1985; Haribabu and Dottin, 1986; Oyama and Blumberg, 1986; Kimmel, 1987; Mann and Firtel, 1987) .
investigate further the requirement of intracellular cAMP for down-regulation. The Sp isomer of 6-thioethylpurineriboside 3',5'-phosphorothioate (6SEth-cPuMPS) does not bind to the surface receptor, enters the cell and has relative high affinity for protein kinase A. 6SEth-cPuMPS alone has no effect on downregulation. However, together with an agonist of the surface receptor, the analogue induces down-regulation in caffeinetreated wild-type cells and in mutant cells lacking adenylate cyclase, but not in mutant cells lacking protein kinase A. These results indicate that intracellular cAMP formation and activation of protein kinase A are essential for down-regulation of the surface cAMP receptor.
Duriug aggregation, extracellular cAMP activates multiple second-messenger enzymes, such as adenylate cyclase, guanylate cyclase and phospholipase C (see Van Haastert et al., 1991) . The second messengers co-ordinate at least two cellular responses, chemotaxis and induction of postaggregative gene expression (see Schaap, 1986) . Besides induction of second messengers and physiological responses, prolonged activation of the receptor also leads to desensitization of sensory transduction (Devreotes and Steck, 1977; Klein and Juliani, 1977; Van Haastert and Van der Heijden, 1983) . Many components are known to contribute to desensitization at the level of cARl (Klein and Juliani, 1977; Klein et al., 1985 Klein et al., , 1987 Van Haastert et al., 1992) : (i) phosphorylation of cARl, which has been suggested to inhibit receptor-G-protein interaction; (ii) functional sequestration of the cARl protein to a state in which it no longer binds cAMP (called loss of ligand binding); (iii) physical sequestration of the cARl protein into patches; (iv) degradation of the receptor (called down-regulation); (v) finally, rapid degradation of cARl mRNA. A detailed genetic and pharmacological study has revealed that each of these components requires partly overlapping but distinct secondmessenger responses (Van Haastert et al., 1992) . The role of intracellular cAMP in desensitization was investigated using caffeine and the mutant synag 7, situations in which receptorstimulated adenylate cyclase is inhibited (Brenner and Thoms, 1984; Theibert and Devreotes, 1983; Schaap et al., 1986) . These experiments revealed that activation of adenylate cyclase is not required for receptor phosphorylation, loss of ligand binding and loss of cARl mRNA. However, the final degradation of the cARl protein does not occur when activation of adenylate cyclase is prevented (Van Haastert et al., 1992) .
Another approach to the study of the function of intracellular cAMP is to use cAMP derivatives that bypass the surface receptor and directly activate the intracellular receptor. In Abbreviations used: cAR, cell surface cAMP receptor; PKA, cAMP-dependent protein kinase; cAMP, adenosine 3',5'-phosphate; cAMPS, adenosine 3',5'-phosphorothioate; 6SEth-cPuMPS, 6-thioethylpurineriboside 3',5'-phosphorothioate; dcAMPS, 2'-deoxyadenosine 3',5'-phosphorothioate. All cAMPS derivatives have the Sp conformation, unless indicated otherwise.
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Dictyostelium these cAMP derivatives require the following properties: (1) resistance to hydrolysis by phosphodiesterase to prevent side effects of metabolites; (2) cell-permeability; (3) high affinity for PKA and low affinity for cARs. Previous studies on the activity of cAMP derivatives (De Wit et al., 1982; Van Haastert and Kien, 1983) were used to select putative candidates from a series of new cAMP analogues designed to activate mammalian PKA (Genieser et al., 1988; Dostman et al., 1990) . Modifications in the adenine moiety provide selectivity for PKA. Lipophilic substitutions were chosen to increase cell permeability. Finally, replacement of an exocyclic oxygen by sulphur dramatically reduces hydrolysis by phosphodiesterase (Rossier et al., 1978; Eckstein, 1985; Braumann et al., 1986) , but also introduces an asymmetric phosphorus atom. The Sp isomer of adenosine 3',5'-phosphorothioate (cAMPS) is an agonist of PKA in mammalian and Dictyostelium cells, whereas the Rp isomer is an antagonist of mammalian PKA (Rothermel et al., 1983) but, unfortunately, not of Dictyostelium PKA (De Wit et al., 1984) . The analogue that best meets the criteria for a selective cell-permeable nonhydrolysable PKA agonist is the (Sp) isomer of 6-thioethylpurineriboside 3'5'-monophosphorothioate (6-SEth-cPuMPS) (Schaap et al., 1993) .
Mutants were recently made that either cannot make intracellular cAMP because of inactivation of the adenylate cyclase gene or cannot respond to intracellular cAMP as a result of inactivation of the catalytic subunit of PKA (Mann et al., 1992) . In the present study, down-regulation of surface receptors is analysed in these mutants, demonstrating that both cell lines lack cAMP-induced degradation of the receptor protein.
The cell-permeable analogue that bypasses the surface receptor and directly activates intracellular PKA is shown to overcome the inhibition ofcAMP-mediated down-regulation in cells lacking adenylate cyclase, but not in cells lacking PKA activity. EXPERIMENTAL Materials [8-3H] cAMP (1.92 TBq/mmol) was obtained from Amersham Corp. (Amersham, Bucks., U.K.). cAMP was obtained from Boehringer (Mannheim, Germany). Dithiothreitol and (Sp)-cAMPS were from Sigma. cAMP analogues were obtained from Biolog (Bremen, Germany) and kindly provided by Dr. Jastorff and Dr. Genieser; their synthesis has been described previously (Genieser et al., 1988) .
Conditions for growth and development D. discoideum mutant cells synag 7 (strain N7) were grown in association with Escherichia coli 281 on a solid medium containing 3.3 g of peptone, 3.3 g of glucose, 4.5 g of KH2PO4, 1.5 g of Na2HPO4,2H20 and 15 g of agar/litre. Wild-type cells (strain AX3) and mutant cells aca-and pk3-were grown in liquid HG5 medium containing 14.3 g of peptone, 10 g of glucose, 7.15 g of yeast extract, 0.49 g of KH2PO4 and 1.36 g of Na2HPO4,2H20 per litre. Control transformants aca-IACG and pk3-/PK3 were grown in HG5 medium supplemented with 10 #g/ml G418. Cells were harvested, washed and resuspended in 10 mM sodium/ potassium phosphate buffer, pH 6.5 (PB buffer).
Loss of ligand binding and down-regulation of surface receptors, analysed by Scatchard plots Cells were starved in suspension for 5 h; mutant cells synag 7, aca-, aca-/ACG and pk3-were pulsed with 0.1 uM cAMP at 5 min intervals. Cells were washed, resuspended in PB buffer, and incubated at a density of 107 cells/ml in the absence or presence of 300 ,uM cAMP for 15 min or 1.5 h.
To assess loss of ligand binding of the receptor, cells were incubated with cAMP for 15 min at 22 'C. They were subsequently collected by centrifugation at 4 'C for 2 min at 700 g, washed twice by centrifugation with ice-cold PB buffer, and resuspended in ice-cold PB buffer. cAMP binding to exposed cARs was measured in a total volume of 100 pl of PB buffer containing different concentrations of [3H]cAMP, 10 mM dithiothreitol and 80,l of the cell suspension (I07 cells, unless stated otherwise). The incubation at 0 'C was terminated after 1 min by centrifugation for 2 min at 14000 g and the supernatant was aspirated.
To assess down-regulation of the receptors, cells were incubated with cAMP for 1.5 h at 22 'C. They were subsequently collected, washed and resuspended in PB buffer as described above. Unless stated otherwise, the suspension was incubated for 20 min at 22 'C, and then placed on ice. cAMP binding to all residual cARs was measured in a total volume of 1 ml of PB buffer containing 78 % satd. (NH4)2SO4, different concentrations of [3H]cAMP, 1 mM dithiothreitol, 50 ,ug of BSA and 80 ,u of cell suspension. The incubation at 0 'C was terminated after 5 min by centrifugation for 2 min at 14000 g and the supernatant was aspirated.
The pellets from both assays were dissolved in 100 Iul of 0.1 M acetic acid, 1.3 ml of Scintillator (Packard 299) was added and radioactivity was determined. Non-specific binding was measured in the presence of 0.1 mM cAMP. To demonstrate that cAMP was effectively removed during the washing procedure, cells were incubated on ice with cAMP for less than 3 s and washed immediately. Binding of cAMP in phosphate buffer and in (NH4)2SO4 to these cells was compared with binding to cells that were not briefly incubated with cAMP; there was no significant difference in the binding data (Van Haastert, 1987) .
Binding curves were fitted to a model ofone or two independent binding sites by non-linear least-squares analysis using the program Pfit. The following equation for two independent binding sites was used (Thakur et al., 1972) :
where Bi and B2 are the maximal binding for binding sites 1 and 2 respectively and K1 and K2 are their dissociation constants.
Model discrimination between one and two binding sites was made by calculating:
where N is the number of data points, p is the number of free parameters and SS is the residual sum of squares; subscripts 1 and 2 denote the smaller and larger model respectively. The degrees of freedom of F are (P1-P2, N-P2). In all cases the twosite model fitted the data significantly better (at P < 0.01) than the one-site model; for aca-/ACG cells ( Figure 2b ) the two-site model was preferred at P < 0.05. Down-regulation of surface receptors induced by cAMP analogues Insufficient quantities of the cAMPS analogues prevent analysis of their effects on cAMP receptors using complete Scatchard plots. Cells were starved as described above. The miniature incubations contained 5 mM caffeine, 300,uM cAMP and/or Table 1 (Figure la) , whereas the reduction in affinity in (NH4)2S04 is completely reversed (Figure ic) .
Treatment of cells for 1.5 h with cAMP leads to a large decrease in binding sites detected in phosphate buffer, which only partly recovers on removal of cAMP (Figure lb) . When these cells are assayed for cAMP binding in (NH4)2SO4, a 2-fold reduction in affinity is observed and a 5000 decrease in the number of binding sites. This reduction in affinity is restored within 20 min on removal of cAMP, but the loss of binding sites is persistent (Figure ld) . These results suggest that a short (15 min) incubation of cells with cAMP leads to loss of about 80 % of exposed binding sites. These sites are still detectable in (NH4)2SO4, but have a reduced affinity, which disappears within 20 min of removal of cAMP. A long (1.5 h) incubation of cells with cAMP also leads to loss of cAMP binding in (NH4)2SO4. Previous experiments have shown that the loss of binding in (NH4)2SO4 is correlated with the loss of receptor protein as detected on Western blots (Van Haastert et al., 1992) . Thus loss of ligand binding is detected in phosphate buffer after treatment of cells with cAMP for 15 min, whereas down-regulation of the receptor is detected in (NH4)2S04 after treatment of the cells with cAMP for 1.5 h followed by a 20 min incubation of these cells without cAMP to restore the reduced affinity of the remaining receptors.
Inhibition of intracellular cAMP formation inhibits down-regulation
Caffeine is a relatively specific inhibitor of receptor-mediated activation of adenylate cyclase in Dictyostelium. This compound completely inhibits cAMP-induced down-regulation, but has no K2 ( Figure 2a) . A second adenylate cyclase gene has been identified, ACG, that is expressed specifically in spores . This gene has been introduced into the aca-cells under the control of the actin-15 promoter which is active during growth and aggregation resulting in cells with high constitutive adenylate cyclase activity (aca-IACG cells; . These aca-/ACG cells were incubated for a short and long period with cAMP, and exposed and total binding sites were measured in phosphate buffer and (NH4) The gene encoding the catalytic subunit of PKA has been identified in Dictyostelium (Burki et al., 1991; Mann and Firtel, 1991) . A pk3-cell line was constructed, in which this gene was inactivated by homologous recombination (Mann et al., 1992) . These cells have a consistently 2-4-fold reduced level of cAMPbinding sites compared with control cells. cAMP induces the normal loss of exposed binding sites during a 15 min incubation (Scatchard plot not shown), but it does not induce downregulation of the cAR in these cells (Table 1 and Figure 3a) . Statistical analysis of the Scatchard plots reveals that cAMP treatment of pk3-cells leads to a shift of high-to low-affinity binding sites and to a reduction in their affinities, but not to a reduction in the total number of binding sites (see Table 1 ). Down-regulation was determined in a control cell line in which PK3 was reintroduced into the pk3-strain under the control of an actin promoter (pk3-/PK3 cells); down-regulation of surface receptors was restored to control values (Table 1 and Figure 3b ).
Cell-permeable PKA agonist and down-regulation of surface receptors Recently analogues of cAMP have been identified that are cellpermeable, resistant to hydrolysis by phosphodiesterase, have high affinity for intracellular PKA and do not bind to the cAR of Dictyostelium (Schaap et al., 1993) . The most potent analogue is 6SEth-cPuMPS; the analogue dcAMPS is used as a control as this compound has a similar polarity to 6SEth-cPuMPS but Table 2 . The results shown are means of triplicate determinations from three (a) or two (b) independent experiments. See Table  1 for statistical analysis of the binding curves.
cannot activate PKA. The experiments presented in Table 2 investigated whether these analogues can restore down-regulation under conditions in which synthesis or detection of intracellular cAMP is absent. Owing to the limited availability of the analogues, the subsequent binding reactions were performed not by Scatchard analysis but at one relatively high [3H]cAMP concentration.
In wild-type AX3 cells, 6SEth-cPuMPS alone does not induce down-regulation, and also does not interfere with cAMP-induced down-regulation (Table 2 ). In the presence of caffeine, 6SEth-cPuMPS together with cAMP induces substantial down-regulation of the surface receptor. 6SEth-cPuMPS cannot be replaced in this response by dcAMPS, a surface-selective agonist. A dose-response curve of 6SEth-cPuMPS-contributed downregulation reveals a half-maximal effect at about 30 ,uM 6SEth-cPuMPS (Table 2) .
The analogue 6SEth-cPuMPS partly restores cAMP-induced down-regulation in the mutant synag 7, which shows a defect in the activation of adenylate cyclase, and in the mutant aca-, which has no adenylate cyclase activity. The analogue cannot restore down-regulation in mutant pk3-, which is defective in PKA (Table 2) .
Summarizing, the experiments demonstrate that down-regulation of cARs does not occur under conditions that specifically Table 2 . The results shown are means of triplicate determinations from three independent experiments. See Table 1 for statistical analysis of the binding curves. Table 2 Recovery of down-regulation by cell-permeable PKA agonist Wild-type AX3 and mutant cells were incubated in the absence or presence of 0.3 mM cAMP, 5 mM caffeine or 6SEth-cPuMPS for 1.5 h. Cells were extensively washed, and binding of 10 nM [3H] cAMP to cell surface receptors was determined in (NH4)2S04 (for mutant pk3 50 nM [3H]cAMP was used to circumvent the change in affinity forms induced by cAMP; see The receptors that do not bind cAMP in phosphate buffer still bind cAMP in nearly saturated (NH4)2SO4 (Van Haastert, 1985) . Thus receptors are not degraded after 15 min of incubation with cAMP. These receptors, however, have changed their affinity for cAMP (Figure 1c ). This change in affinity is reversible on removal of cAMP with a half-time of several minutes ( Figure 1 ). As mentioned above, incubation of cells with cAMP for 15 min leads to phosphorylation of the receptor and loss of ligand binding in phosphate buffer. The following experiments suggest that the reduced affinity in (NH4)2SO4 is related to phosphorylation of the receptor rather than loss of ligand binding. The analogue (Rp)-cAMPS induces loss of ligand binding but not the phosphorylation of the receptor; cells treated with (Rp)-cAMPS have receptors with a normal binding affinity in (NH4)2SO4 (Van Haastert et al., 1992) . Secondly, the affinity of the receptor is restored to control values after a 20 min incubation at 22°C (Figure 1) ; dephosphorylation of cARl occurs with similar characteristics (Klein et al., 1987) , whereas loss of ligand binding reverts much more slowly at 22°C (Van Haastert, 1987) . The decrease in binding affinity hinders the rapid detection of the number of binding sites, as complete Scatchard analysis should be carried out for each experiment. The affinity of the receptor is restored relatively rapidly at 22°C (20 min), whereas de novo synthesis of the receptor is slow [several hours (Van Haastert et al., 1992) ]. Therefore the optimum protocol for measuring downregulation is incubation ofthe cells with cAMP for 1.5 h, removal of cAMP and subsequent incubation for 20 min at 22°C, followed by the binding assay in (NH4)2SO4. With this protocol, cAMP induces about 500% down-regulation of cARs. Intracellular cAMP appears to play an essential role in this process.
Previous experiments with the drug caffeine and the mutant synag 7 suggested that down-regulation may require receptormediated activation of adenylate cyclase (Van Haastert et al., 1992) . In the present report down-regulation of surface cAMP receptors was investigated using a combination of specific mutants defective in adenylate cyclase and the catalytic subunit of PKA (Mann et al., 1992 ) with non-hydrolysable cAMP derivatives designed to activate intracellular PKA in Dictyostelium (Schaap et al., 1993) . 6SEth-cPuMPS was selected from a large group of analogues (Genieser et al., 1988) 
